Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy, being studied in advanced or metastatic solid tumors. The study is …
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome [NA]
A completed clinical trial evaluating whether prolonged nightly fasting influences immunotherapy outcomes in head and neck cancer and the ro…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Heavy Strength Training in Head and Neck Cancer Survivors [Phase 2]
Phase 2 clinical trial evaluating heavy strength training in head and neck cancer survivors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy [Phase 2]
A Phase 2 clinical trial in HPV 16/18-positive recurrent or metastatic head and neck squamous cell carcinoma evaluating a triple therapy of …
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer [Phase 2]
A Phase 2 trial is evaluating a combination of GX-188E vaccination, GX-I7, and pembrolizumab in patients with advanced, resectable HPV16/18-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 neoadjuvant trial evaluating Becotatug Vedotin with Pucotenlimab and Cisplatin in locally advanced head and neck squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating a binary oncolytic adenovirus in combination with a HER2-specific autologous CAR-VST for advanced HER2-pos…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
This clinical trial update shows that a study on circulating tumor DNA (ctDNA) in locally advanced head and neck squamous cell carcinoma is …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Longitudinal Oral Health Changes After Head and Neck Radiotherapy
ClinicalTrials.gov update describing an ongoing longitudinal study of oral health changes in patients after radiotherapy for head and neck c…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of SH009 Injection in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 clinical trial update for SH009 Injection in patients with advanced solid tumors, currently recruiting across multiple indications…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck [Phase 2]
This Phase 2 trial update assesses dual EGFR inhibition with afatinib and cetuximab in advanced head and neck squamous cell carcinoma, with …
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant low-dose radiotherapy combined with anti-PD-1 immunotherapy for resectable locally advanced he…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma [NA]
A completed clinical trial evaluating hypofractionated radiotherapy in elderly patients with head and neck squamous cell carcinoma (NCT04284…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer [Phase 1]
Phase 1 trial evaluating combining immunotherapy salvage surgery with intraoperative radiotherapy (IORT) for head and neck cancer, including…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer [Phase 3]
Ongoing Phase 3 trial evaluating pembrolizumab with radiotherapy for oligometastatic head and neck squamous cell carcinoma is currently recr…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase II trial evaluating an anti-EGFR antibody-drug conjugate as neoadjuvant therapy for resectable locally advanced head and neck squamous…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC [Phase 2]
A Phase 2 trial evaluating danvatirsen in combination with pembrolizumab for head and neck squamous cell carcinoma has been terminated, with…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
A Phase II, single-arm, multicenter clinical trial evaluating the perioperative use of sintilimab in patients with resectable locally advanc…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: PDT For Induction Therapy For Head And Neck Cancer [Phase 2]
Phase 2 clinical trial update on photodynamic therapy as induction therapy for head and neck cancer. The trial is currently not yet recruiti…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating metformin hydrochloride in combination with doxycycline for head and neck squamous cell carcinoma has be…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade [Phase 1, Phase 2]
Phase 1/2 trial evaluating interleukin-2 with radiotherapy and pembrolizumab in patients refractory to checkpoint blockade; results have bee…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-B01D1 in patients with metastatic or unresectable non-small cell lung cancer and other solid tumors is …
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with cetuximab for recurrent/metastatic head and neck squamous cell carcinoma; the stu…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719 [NA]
A completed window-of-opportunity trial in head and neck squamous cell carcinoma evaluated biomarker modulation after preoperative BYL719 (a…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer [NA]
A clinical trial evaluating multispectral optoacoustic tomography in head and neck squamous cell carcinoma has been suspended.